Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nationally Recognized Hair Loss Expert Dr. Alan J. Bauman to Speak November 9th at Palm Beach County Stem Cell Fellowship
  • USA - English


News provided by

Firm Nineteen, LLC

Nov 07, 2013, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Alan J. Bauman, M.D., a leading expert in the field of hair science
Alan J. Bauman, M.D., a leading expert in the field of hair science

The medical community has been studying the applicability of platelet-rich plasma therapy for many years, but only recently have we begun to look into its potential for hair loss patients.

Post this

Boca Raton, FL (PRWEB) November 07, 2013 -- Internationally recognized hair restoration expert Alan J. Bauman, M.D. is a featured speaker at the American Academy of Anti-Aging Medicine’s (A4M) Stem Cell Fellowship, November 8-9 at the South Florida Bone Marrow Stem Cell Transplant Institute in Boynton Beach, Florida. Dr. Bauman, who speaks on Saturday, November 9th, is presenting research on the use of platelet-rich plasma (PRP), also known as the “Vampire” treatment, for wound healing after hair transplantation and as a stand-alone treatment for stimulating hair growth. The event is hosted by Dr. Dipnarine Maharaj, medical director of the institute and medical director of the American Academy of Anti-Aging Medicine’s Stem Cell Fellowship.

“PRP is an exciting new treatment for hair loss patients, with considerable potential both in terms of new growth stimulation and also for faster wound-healing after surgical procedures,” Dr. Bauman said. “My talk will explore the work we’ve done at Bauman Medical Group with this relatively new treatment for hair follicle rejuvenation and provide helpful insights and lessons for other doctors who want to incorporate it into their own practices. We will also be discussing the adjunctive use of extracellular matrix products like ACell/Matristem and a new, FDA-approved human-harvested stem cell-containing extracellular matrix product called Amnio-MTM (BioD) derived from human amnion (placental) tissue. Dr. Maharaj is a well-known and highly respected figure in the stem cell field and I’m honored to have been asked to participate in this program.”

PRP is a natural, side-effect free regenerative treatment with multiple applications, including nerve damage, cardiac muscle injury, bone and ligament repair/regeneration, and is gaining popularity in many areas of medicine, such as sports medicine, oral surgery and plastic surgery. Bauman is one of the few US doctors to use PRP as a treatment for hair loss, and he’s been studying its effectiveness on patients for over two years at his Boca Raton clinic. A recent study published in the British Journal of Dermatology found that PRP treatments helped to reverse a specific type of hair loss called alopecia areata.

“The medical community has been studying the applicability of platelet-rich plasma therapy for many years, but only recently have we begun to look into its potential for hair loss patients,” Bauman said. “What initially began as a way to repair damaged nerves, tissues, ligaments, joints, tendons and bones is now being seen as a way to stimulate this same type of cellular growth cosmetically for facial rejuvenation, and in the case of androgenetic alopecia and alopecia areata, as a way to rejuvenate weakened follicles and produce hair regrowth without drugs or surgery.”

About PRP for Hair Regrowth:

• Platelets, when ‘activated,’ release powerful molecules, growth factors and cytokines that can have profound biologic effects on hair follicles and skin.
• PRP can be used to enhance hair growth as a stand-alone treatment and/or to improve the recovery and results of hair transplant surgery. Often the procedures are combined.
• As part of hair transplantation, PRP can be used to store grafts while they are outside the body awaiting implantation, improve graft survival, and accelerate wound healing.
• Adding extracellular matrix (ECM) tissue-regenerating technology, like ACell/Matristem or BioD/AmnioMTM, the PRP treatments can be “supercharged” in hair restoration treatments.
• The application of PRP to the scalp requires a short outpatient visit and no recovery or downtime. Results generally begin to show after 90 days. Additional treatments may be necessary in order to achieve desired results.
• Research is currently underway to demonstrate PRP’s effectiveness as a preventative treatment for hair disorders.

For patients or doctors who are interested in more information about PRP for hair regrowth, visit http://www.baumanmedical.com, or call 1-877-BAUMAN-9 or 561-394-0024.

About the Stem Cell Fellowship:

Dr. Dipnarine Maharaj created the world’s first Stem Cell Fellowship program, in conjunction with the American Academy of Anti-Aging Medicine (A4M), to educate physicians and healthcare professionals about the growing body of research on stem cell therapies. Stem cell therapies involve the potential replacement of cells or organs that are diseased, injured, infirmed, ailing or aged. In this modular training program for doctors, a group of experienced academics involved in stem cell transplantation present a series of topics to cover the general principles and practices of stem cell biology and evidence-based treatments for physicians to optimize the health of their patients. After completing this program, physicians will be able to intelligently decide which stem cell protocols to recommend to their patients.

The November 8-9th Stem Cell Fellowship event is the final module of this training program for physicians. It is a practical module that will feature talks from stem cell expert speakers from around the U.S. as well as hands-on training. The event is being held at the South Florida Bone Marrow Stem Cell Transplant Institute in Boynton Beach, Florida.

To learn more about the Stem Cell Fellowship, register for any event, enroll in any training program, or to exhibit at any A4M Conference, please contact the office of the American Academy of Anti-Aging medicine at 888-997-0112 or email: info(at)a4m(dot)com.

About Dr. Alan J. Bauman:

Alan J. Bauman, M.D. is a full-time hair transplant surgeon who has treated over 15,000 patients and performed over 6,000 surgical procedures since starting his hair loss practice, Bauman Medical Group, P.A. in 1997 located in Boca Raton, FL.

Dr. Bauman received his M.D. degree from New York Medical College and surgical residency training at Mt. Sinai Medical Center and Beth Israel Medical Center in New York. Dr. Bauman is one of approximately 100 physicians worldwide to achieve certification from the esteemed American and International Board of Hair Restoration Surgery. He has been an active member of the International Society of Hair Restoration Surgery as a participant and lecturer at numerous Annual Scientific Meetings and Live Surgery Workshops.

Dr. Bauman is an author of textbook chapters on the science of hair care and hair transplantation, including eyelash transplant surgery, and has been extensively featured in the world’s leading media as a medical expert and successful early-adopter of some of the most advanced technologies in the treatment of hair loss such as laser therapy and NeoGraft FUE hair transplantation.

Dr. Bauman has been featured extensively in the world’s leading media in print, radio and television as a medical expert and successful early-adopter of the most advanced technologies in the treatment of hair loss. Appearances, interviews and profiles include the Today Show, The Early Show, Good Morning America, Extra, Access Hollywood and Dateline NBC among other TV appearances. Newspaper and Magazine articles and feature stories include The New York Times, Newsweek, Cosmo, Vogue, Allure, O – The Oprah Magazine and Men’s Health among others.

About Dr. Dipnarine Maharaj:

Dipnarine Maharaj, M.D., MB, ChB, FRCP (Glasgow), FRCP (Edinburgh), FRCPath., FACP is an American physician, author, clinical researcher and Founder & Medical Director of the South Florida Bone Marrow Stem Cell Transplant Institute and the Stem Cell Cryobank located in Boynton Beach, Florida. The Institute is one of the few completely outpatient stem cell transplant facilities in the US and is FDA registered, Joint Commission Accredited (JCAHO), and accredited by the AABB. He received his medical degree in 1978 from the University of Glasgow and completed his internship and residency in Internal Medicine and Hematology at the University's Royal Infirmary.

Maharaj is the author of more than 60 published research papers and abstracts on bone marrow and stem cell transplantation for blood disorders, cancers, Parkinson’s, and other inflammatory diseases. He has developed a new protocol for Parkinson’s disease patients, for which he was awarded a U.S. patent. Currently he is running an FDA approved Phase I/Phase II clinical trial for solid tumor cancers. He was profiled by Suzanne Somers for his work with cancer in her book Bombshell: Explosive Medical Secrets that will Redefine Aging (2012) where she categorized him as “America’s Leading Expert on Stem Cell Technologies.”

Janet Shoup, Firm Nineteen, LLC, 828-424-0983, [email protected]

Modal title

Dr. Alan Bauman films an interview with ABC-25 on his pioneering work in "Vampire PRP" treatment
Dr. Alan Bauman films an interview with ABC-25 on his pioneering work in "Vampire PRP" treatment
Dr. Alan Bauman examines a female "Vampire PRP" patient
Dr. Alan Bauman examines a female "Vampire PRP" patient
Dr. Alan Bauman treats a male patient with "Vampire PRP"
Dr. Alan Bauman treats a male patient with "Vampire PRP"
Dr. Alan Bauman is one of the first US doctors to use "Vampire PRP" treatments with hair loss patients
Dr. Alan Bauman is one of the first US doctors to use "Vampire PRP" treatments with hair loss patients
"Vampire PRP" uses a patient's own modified blood to stimulate hair restoration
"Vampire PRP" uses a patient's own modified blood to stimulate hair restoration
Dr. Alan Bauman prepares a "Vampire PRP" treatment for a patient
Dr. Alan Bauman prepares a "Vampire PRP" treatment for a patient
Male PRP patient - 8 months before-and-after
Male PRP patient - 8 months before-and-after
Male PRP patient - 12 weeks before-and-after
Male PRP patient - 12 weeks before-and-after
Male PRP patient - 9 months before-and-after
Male PRP patient - 9 months before-and-after
Dr. Alan Bauman films an interview with ABC-25 on his pioneering work in "Vampire PRP" treatment Dr. Alan Bauman examines a female "Vampire PRP" patient Dr. Alan Bauman treats a male patient with "Vampire PRP" Dr. Alan Bauman is one of the first US doctors to use "Vampire PRP" treatments with hair loss patients "Vampire PRP" uses a patient's own modified blood to stimulate hair restoration Dr. Alan Bauman prepares a "Vampire PRP" treatment for a patient Male PRP patient - 8 months before-and-after Male PRP patient - 12 weeks before-and-after Male PRP patient - 9 months before-and-after

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.